Exploring lactylation and cancer biology: insights from pathogenesis to clinical applications

As a byproduct of glycolysis, lactate functions as a signaling molecule, a substrate for energy metabolism, and a regulator of the tumor microenvironment (TME). It is involved in various biological processes, including energy shuttling, tumor growth and invasion, drug resistance, and immune evasion....

Full description

Saved in:
Bibliographic Details
Main Authors: Zixuan Gou, Qianchuang Sun, Jiannan Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2025.1598232/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850158516415758336
author Zixuan Gou
Qianchuang Sun
Jiannan Li
author_facet Zixuan Gou
Qianchuang Sun
Jiannan Li
author_sort Zixuan Gou
collection DOAJ
description As a byproduct of glycolysis, lactate functions as a signaling molecule, a substrate for energy metabolism, and a regulator of the tumor microenvironment (TME). It is involved in various biological processes, including energy shuttling, tumor growth and invasion, drug resistance, and immune evasion. Lactylation, a recently identified post-translational modification (PTM), acts as a bridge between gene regulation and cellular metabolism, thus playing a crucial role in tumor biology. Similar to other epigenetic modifications, lactylation influences the spatial conformation of chromatin, modulates DNA accessibility, and regulates gene expression. It intricately participates in TME-related processes by orchestrating immune state transitions and enhancing the malignant characteristics of tumors. This review summarizes lactylation-related genes in tumors, the role of lactylation in the TME, the interactions of the genes with other metabolic pathways, and the potential mechanisms underlying tumor progression as well as their clinical implications. Despite its nascent stage, research on the epigenetic regulation of tumor-related genes by lactylation holds promise. In this review, we highlighted unresolved challenges in this field and provided insights that may guide the development of novel targeted therapies for cancer.
format Article
id doaj-art-ae5890daf3c449be9e73a8112edd99bb
institution OA Journals
issn 2296-634X
language English
publishDate 2025-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj-art-ae5890daf3c449be9e73a8112edd99bb2025-08-20T02:23:51ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2025-06-011310.3389/fcell.2025.15982321598232Exploring lactylation and cancer biology: insights from pathogenesis to clinical applicationsZixuan Gou0Qianchuang Sun1Jiannan Li2Department of Hematology, The Second Hospital of Jilin University, Changchun, ChinaDepartment of Operating Theater and Anesthesiology, The Second Hospital of Jilin University, Changchun, ChinaDepartment of General Surgery, The Second Hospital of Jilin University, Changchun, ChinaAs a byproduct of glycolysis, lactate functions as a signaling molecule, a substrate for energy metabolism, and a regulator of the tumor microenvironment (TME). It is involved in various biological processes, including energy shuttling, tumor growth and invasion, drug resistance, and immune evasion. Lactylation, a recently identified post-translational modification (PTM), acts as a bridge between gene regulation and cellular metabolism, thus playing a crucial role in tumor biology. Similar to other epigenetic modifications, lactylation influences the spatial conformation of chromatin, modulates DNA accessibility, and regulates gene expression. It intricately participates in TME-related processes by orchestrating immune state transitions and enhancing the malignant characteristics of tumors. This review summarizes lactylation-related genes in tumors, the role of lactylation in the TME, the interactions of the genes with other metabolic pathways, and the potential mechanisms underlying tumor progression as well as their clinical implications. Despite its nascent stage, research on the epigenetic regulation of tumor-related genes by lactylation holds promise. In this review, we highlighted unresolved challenges in this field and provided insights that may guide the development of novel targeted therapies for cancer.https://www.frontiersin.org/articles/10.3389/fcell.2025.1598232/fulllactylationpost-translational modificationtumor progressionprognostic biomarkerstherapeutic target
spellingShingle Zixuan Gou
Qianchuang Sun
Jiannan Li
Exploring lactylation and cancer biology: insights from pathogenesis to clinical applications
Frontiers in Cell and Developmental Biology
lactylation
post-translational modification
tumor progression
prognostic biomarkers
therapeutic target
title Exploring lactylation and cancer biology: insights from pathogenesis to clinical applications
title_full Exploring lactylation and cancer biology: insights from pathogenesis to clinical applications
title_fullStr Exploring lactylation and cancer biology: insights from pathogenesis to clinical applications
title_full_unstemmed Exploring lactylation and cancer biology: insights from pathogenesis to clinical applications
title_short Exploring lactylation and cancer biology: insights from pathogenesis to clinical applications
title_sort exploring lactylation and cancer biology insights from pathogenesis to clinical applications
topic lactylation
post-translational modification
tumor progression
prognostic biomarkers
therapeutic target
url https://www.frontiersin.org/articles/10.3389/fcell.2025.1598232/full
work_keys_str_mv AT zixuangou exploringlactylationandcancerbiologyinsightsfrompathogenesistoclinicalapplications
AT qianchuangsun exploringlactylationandcancerbiologyinsightsfrompathogenesistoclinicalapplications
AT jiannanli exploringlactylationandcancerbiologyinsightsfrompathogenesistoclinicalapplications